Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials.

BMC Cancer · 2025 · PMC12523153 · PMID 41088012

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Although our pooled point estimate suggests a numerical trend towards greater PFS benefit in the recurrent disease subgroup (HR, 0.63) compared to the newly diagnosed subgroup (HR, 0.87), the test for interaction was not statistically significant ( p -interaction = 0.3795).

also in 624 other papers

did not reach statistical significanceno p-value reported

recurrent; p -interaction = 0.3795) did not reach statistical significance.

also in 57,694 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.